Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
GLP-1s increased the release of insulin but had an extremely short half-life (one to two minutes), making them highly unfavorable as a treatment for diabetes
Entry-level branded Wegovy pill vs Cora compounded semaglutide, monthly Cora: $120/month (6-month plan) or $99/month (annual plan)
They work by mimicking a hormone your body already produces naturally: GLP-1 (glucagon-like peptide-1)
This formulation helps patients tolerate treatment more consistently from the very first dose
Women who become pregnant during a clinical trial should discontinue treatment immediately and inform their trial team
